Researchers have developed technologies that allow damaged proteins to be shredded or healthy ones installed. This may ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells.

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune cells, making organs like the liver more resistant to metastatic cancer.

New melanoma immunotherapy research reveals how changing the way tumors die can awaken immune defenses and improve outcomes in mice.

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug ...

Researchers have uncovered a complex biological process that protects germ cells, the precursor cells to sperm, from genetic ...

Your sperm may age faster than you think. Researchers uncovered a molecular clock that could affect your child’s health ...